标题
Adenoviral vector-based strategies against infectious disease and cancer
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 12, Issue 8, Pages 2064-2074
出版商
Informa UK Limited
发表日期
2016-04-22
DOI
10.1080/21645515.2016.1165908
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- The induction of antigen-specific CTL by in situ Ad-REIC gene therapy
- (2016) Y Ariyoshi et al. GENE THERAPY
- Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
- (2016) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals
- (2015) Gary Wong et al. ANTIVIRAL RESEARCH
- In vitro antitumor immune response induced by dendritic cells transduced with human livin α recombinant adenovirus
- (2015) Junping Xie et al. CELLULAR IMMUNOLOGY
- Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge
- (2015) H Zhang et al. GENE THERAPY
- Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
- (2015) Xiaojuan Guo et al. IMMUNOLOGY
- Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates
- (2015) Gary Wong et al. JOURNAL OF INFECTIOUS DISEASES
- High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial
- (2015) David Liebowitz et al. LANCET INFECTIOUS DISEASES
- Single-Molecule Analysis of the Target Cleavage Reaction by the Drosophila RNAi Enzyme Complex
- (2015) Chunyan Yao et al. MOLECULAR CELL
- Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
- (2015) Surender Khurana et al. PLoS One
- Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development
- (2015) Cheng Cheng et al. VACCINE
- The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
- (2015) Matthew D.J. Dicks et al. VACCINE
- Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71
- (2015) Chao Zhang et al. VACCINE
- Recent developments in clinical trial designs for HIV vaccine research
- (2015) Laura Richert et al. Human Vaccines & Immunotherapeutics
- Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses
- (2015) Richard J. Webby et al. PLoS One
- A Replicating Adenovirus Capsid Display Recombinant Elicits Antibodies against Plasmodium falciparum Sporozoites in Aotus nancymaae Monkeys
- (2014) Kasey A. Karen et al. INFECTION AND IMMUNITY
- Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans
- (2014) Lindsey R. Baden et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
- (2014) Eun Kim et al. VACCINE
- Protection of non-human primates against rabies with an adenovirus recombinant vaccine
- (2014) Z.Q. Xiang et al. VIROLOGY
- Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
- (2014) Xiang Wang et al. Emerging Microbes & Infections
- Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models
- (2014) Yudan Chi et al. Molecular Therapy-Nucleic Acids
- Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma
- (2013) Misato Takagi-Kimura et al. CANCER SCIENCE
- Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study
- (2013) Marc Gurwith et al. LANCET INFECTIOUS DISEASES
- Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial
- (2013) Manfred Westphal et al. LANCET ONCOLOGY
- Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1
- (2013) Robert Schwenk et al. MALARIA JOURNAL
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
- (2013) Scott M. Hammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
- (2013) Ilin Chuang et al. PLoS One
- Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa
- (2013) Anurag Sharma et al. PLoS One
- Broadly Protective Adenovirus-Based Multivalent Vaccines against Highly Pathogenic Avian Influenza Viruses for Pandemic Preparedness
- (2013) Sai V. Vemula et al. PLoS One
- A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age
- (2013) Alphonse Ouédraogo et al. PLoS One
- A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity
- (2013) F. Smaill et al. Science Translational Medicine
- Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans
- (2013) Wendy Peters et al. VACCINE
- Human adenovirus 5-vectoredPlasmodium falciparumNMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
- (2013) Cindy Tamminga et al. Human Vaccines & Immunotherapeutics
- HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice
- (2012) S H MacLeod et al. CANCER GENE THERAPY
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)
- (2012) Lindsey R. Baden et al. JOURNAL OF INFECTIOUS DISEASES
- Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
- (2012) Dan H. Barouch et al. JOURNAL OF INFECTIOUS DISEASES
- Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+T Cells Induced by Different Adenovirus Vectors
- (2012) Wendy G. Tan et al. JOURNAL OF VIROLOGY
- Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys
- (2012) Jeffrey E. Teigler et al. JOURNAL OF VIROLOGY
- Unknown
- (2012) Sayma Rahman et al. MOLECULAR MEDICINE
- ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans
- (2012) Susanne H Sheehy et al. MOLECULAR THERAPY
- Hexon-modified Recombinant E1-deleted Adenovirus Vectors as Dual Specificity Vaccine Carriers for Influenza Virus
- (2012) Dongming Zhou et al. MOLECULAR THERAPY
- Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon
- (2012) Xingui Tian et al. PLoS One
- MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
- (2012) Holly Janes et al. PLoS One
- A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults
- (2012) Michael C. Keefer et al. PLoS One
- Adenovirus receptors: implications for targeting of viral vectors
- (2012) Niklas Arnberg TRENDS IN PHARMACOLOGICAL SCIENCES
- A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity
- (2012) Daniel F. Hoft et al. VACCINE
- Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1
- (2012) Hideyo Ugai et al. VIROLOGY
- Evolution of oncolytic adenovirus for cancer treatment
- (2011) Joung-Woo Choi et al. ADVANCED DRUG DELIVERY REVIEWS
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
- (2011) Nicole Frahm et al. JOURNAL OF CLINICAL INVESTIGATION
- Computational Analysis of Two Species C Human Adenoviruses Provides Evidence of a Novel Virus
- (2011) M. P. Walsh et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Adenovirus Core Protein VII Protects the Viral Genome from a DNA Damage Response at Early Times after Infection
- (2011) K. A. Karen et al. JOURNAL OF VIROLOGY
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- A Single Sublingual Dose of an Adenovirus-Based Vaccine Protects against Lethal Ebola Challenge in Mice and Guinea Pigs
- (2011) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
- (2011) Nancy J Sullivan et al. NATURE MEDICINE
- A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)
- (2011) Gavin J. Churchyard et al. PLoS One
- Head and neck cancer: Response to p53-based therapeutics
- (2010) Jackie Nemunaitis et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Ebola haemorrhagic fever
- (2010) Heinz Feldmann et al. LANCET
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis
- (2010) Emma C Nilsson et al. NATURE MEDICINE
- Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses
- (2010) Richard A. Koup et al. PLoS One
- Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein Networks
- (2010) H. Liu et al. SCIENCE
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep
- (2010) Coraline Bouet-Cararo et al. VACCINE
- Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors
- (2010) Jeroen de Vrij et al. VIROLOGY
- Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine
- (2010) Glenda Gray et al. Current Opinion in HIV and AIDS
- A Capsid-Encoded PPxY-Motif Facilitates Adenovirus Entry
- (2010) Harald Wodrich et al. PLoS Pathogens
- Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent Squamous Cell Carcinoma of the Head and Neck
- (2009) J. Nemunaitis et al. CLINICAL CANCER RESEARCH
- New Insights on Adenovirus as Vaccine Vectors
- (2009) Marcio O Lasaro et al. MOLECULAR THERAPY
- Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
- (2009) A. Benlahrech et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity
- (2009) Saima Khanam et al. VACCINE
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
- (2008) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Localization of the N-Terminus of Minor Coat Protein IIIa in the Adenovirus Capsid
- (2008) Carmen San Martín et al. JOURNAL OF MOLECULAR BIOLOGY
- Latent Species C Adenoviruses in Human Tonsil Tissues
- (2008) C. T. Garnett et al. JOURNAL OF VIROLOGY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
- AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer
- (2008) B. Nie et al. MOLECULAR CANCER THERAPEUTICS
- Insights into adenovirus host cell interactions from structural studies
- (2008) G.R. Nemerow et al. VIROLOGY
- Serum-free transient protein production system based on adenoviral vector and PER.C6 technology: High yield and preserved bioactivity
- (2007) M.J.E. Havenga et al. BIOTECHNOLOGY AND BIOENGINEERING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now